Compare Stocks: ACB, GUD, and THCX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACB Aurora Cannabis	$3.99 -2.7%	$3.98	$2.56 ▼ $6.36	$269.47M	0.63	1.17 million shs	982,778 shs
GUD Knight Therapeutics	C$11.04 +2.2%	C$10.05	C$5.66 ▼ C$11.16	C$1.08B	-0.449151	93,914 shs	82,225 shs
THCX AXS Cannabis ETF	$16.60	$16.60	$14.90 ▼ $25.40	$141.07M	1.71	15,071 shs	N/A

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACB Aurora Cannabis	-2.68%	-11.14%	+4.18%	+51.71%	-29.13%
GUD Knight Therapeutics	+2.22%	+1.94%	+10.29%	+12.42%	+92.00%
THCX AXS Cannabis ETF	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACB Aurora Cannabis	$3.99 -2.7%	$3.98	$2.56 ▼ $6.36	$269.47M	0.63	1.17 million shs	982,778 shs
GUD Knight Therapeutics	C$11.04 +2.2%	C$10.05	C$5.66 ▼ C$11.16	C$1.08B	-0.449151	93,914 shs	82,225 shs
THCX AXS Cannabis ETF	$16.60	$16.60	$14.90 ▼ $25.40	$141.07M	1.71	15,071 shs	N/A

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACB Aurora Cannabis	-2.68%	-11.14%	+4.18%	+51.71%	-29.13%
GUD Knight Therapeutics	+2.22%	+1.94%	+10.29%	+12.42%	+92.00%
THCX AXS Cannabis ETF	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACB Aurora Cannabis	2.00	Hold	N/A	N/A
GUD Knight Therapeutics	3.00	Buy	C$9.50	-13.95% Downside
THCX AXS Cannabis ETF	2.03	Hold	$16.60	N/A

Current Analyst Ratings Breakdown

Latest ACB, GUD, and THCX Analyst Ratings

Date	Company	Brokerage	Action	Rating
10/5/2026	ACB Aurora Cannabis	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
10/2/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/16/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/26/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/11/2026	ACB Aurora Cannabis	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D) ➝ Sell (E+)
8/7/2026	ACB Aurora Cannabis	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
8/5/2026	ACB Aurora Cannabis	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold

(Data available from 10/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACB Aurora Cannabis	$247.82M	1.06	$0.68 per share	5.84	$6.27 per share	0.64
GUD Knight Therapeutics	C$547.31M	1.98	C$2.87 per share	3.85	C$8.13 per share	1.36
THCX AXS Cannabis ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACB Aurora Cannabis	-$88.13M	-$1.41	N/A	66.50	N/A	-32.26%	4.37%	3.45%	11/4/2026 (Estimated)
GUD Knight Therapeutics	-C$30.73M	C$0.15	73.60	N/A		2.72%	1.91%	0.51%	N/A
THCX AXS Cannabis ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest ACB, GUD, and THCX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q2 2027	ACB Aurora Cannabis	-$0.03	N/A	N/A	N/A	$50.68 million	N/A
8/6/2026	Q2 2026	GUD Knight Therapeutics	N/A	-C$0.03	N/A	-C$0.03	N/A	C$143.97 million
8/5/2026	Q1 2027	ACB Aurora Cannabis	-$0.13	$0.04	+$0.17	-$0.05	$47.45 million	$47.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACB Aurora Cannabis	N/A	N/A	N/A	N/A	N/A
GUD Knight Therapeutics	N/A	N/A	N/A	N/A	N/A
THCX AXS Cannabis ETF	$0.72	4.34%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACB Aurora Cannabis	0.03	5.36	2.80
GUD Knight Therapeutics	4.29	2.28	1.79
THCX AXS Cannabis ETF	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACB Aurora Cannabis	47.63%
GUD Knight Therapeutics	22.74%
THCX AXS Cannabis ETF	N/A

Insider Ownership

Company	Insider Ownership
ACB Aurora Cannabis	0.01%
GUD Knight Therapeutics	45.62%
THCX AXS Cannabis ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACB Aurora Cannabis	1,028	65.72 million	65.72 million	Optionable
GUD Knight Therapeutics	830	98.23 million	N/A	Not Optionable
THCX AXS Cannabis ETF	N/A	8.50 million	N/A	Not Optionable

ACB, GUD, and THCX Headlines

Recent News About These Companies

Herbal Dispatch Ships 3,000 Units of 2026 Happy Hour Holiday Cannabis Calendar to BCLDB Following Sold-Out 2025 Edition

October 15 at 7:00 AM | newsfilecorp.comN

Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside

October 14 at 4:00 PM | prnewswire.com

'Let's Go All In On Cannabis' Grown Rogue's Obie Strickler & Josh Rosen

September 8, 2026 | seekingalpha.com

The Cannabis M&A Wave Is Here. Curaleaf Proved It.

August 23, 2026 | fool.com

Christina Lake Cannabis Announces Non-Binding Letter of Intent

August 21, 2026 | globenewswire.com

NewLake Capital: Discounted Cannabis REIT Offers Inflation-Beating Yields And Rich Upsides

August 18, 2026 | seekingalpha.com

Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels

August 11, 2026 | seekingalpha.com

Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

August 9, 2026 | seekingalpha.com

Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Innovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating Thesis

June 30, 2026 | seekingalpha.com

Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement

June 22, 2026 | newsfilecorp.comN

Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy

June 12, 2026 | seekingalpha.com

Herbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To Europe

June 9, 2026 | newsfilecorp.comN

Herbal Dispatch Completes Export of 261kg of Medical Cannabis to Europe

May 21, 2026 | newsfilecorp.comN

Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe

May 19, 2026 | newsfilecorp.comN

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science

May 14, 2026 | prnewswire.com

Village Farms: U.S. Cannabis Optionality (Rating Upgrade)

May 13, 2026 | seekingalpha.com

Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling

May 12, 2026 | seekingalpha.com

Innovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate Buy

May 6, 2026 | seekingalpha.com

Herbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis Segment

May 5, 2026 | newsfilecorp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ACB, GUD, and THCX Company Descriptions

Aurora Cannabis NASDAQ:ACB

$3.99 -0.11 (-2.68%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$3.99 +0.00 (+0.05%)

As of 10/16/2026 08:00 PM Eastern

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Knight Therapeutics TSE:GUD

C$11.04 +0.24 (+2.22%)

As of 10/16/2026 04:00 PM Eastern

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc.'s shares trade on the TSX under the symbol GUD. For more information about Knight Therapeutics Inc., please visit the company's web site at www.knighttx.com or www.sedarplus.ca.

AXS Cannabis ETF NYSEARCA:THCX

$16.60 0.00 (0.00%)

As of 03/1/2024

The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACB, GUD, and THCX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACB, GUD, and THCX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACB, GUD, and THCX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACB, GUD, and THCX Company Descriptions

Aurora Cannabis NASDAQ:ACB

Knight Therapeutics TSE:GUD

AXS Cannabis ETF NYSEARCA:THCX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ACB, GUD, and THCX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ACB, GUD, and THCX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ACB, GUD, and THCX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ACB, GUD, and THCX Company Descriptions

Aurora Cannabis NASDAQ:ACB

Knight Therapeutics TSE:GUD

AXS Cannabis ETF NYSEARCA:THCX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools